351 related articles for article (PubMed ID: 15692088)
1. Insulin-like growth factor-I regulates proliferation and osteoblastic differentiation of calcifying vascular cells via extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase pathways.
Radcliff K; Tang TB; Lim J; Zhang Z; Abedin M; Demer LL; Tintut Y
Circ Res; 2005 Mar; 96(4):398-400. PubMed ID: 15692088
[TBL] [Abstract][Full Text] [Related]
2. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination.
Ogata T; Iijima S; Hoshikawa S; Miura T; Yamamoto S; Oda H; Nakamura K; Tanaka S
J Neurosci; 2004 Jul; 24(30):6724-32. PubMed ID: 15282275
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
Kurihara S; Hakuno F; Takahashi S
Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells.
Shoba LN; Lee JC
J Cell Biochem; 2003 Apr; 88(6):1247-55. PubMed ID: 12647306
[TBL] [Abstract][Full Text] [Related]
6. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
Qiao M; Shapiro P; Kumar R; Passaniti A
J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
[TBL] [Abstract][Full Text] [Related]
9. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
10. Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK.
Zhang W; Shen X; Wan C; Zhao Q; Zhang L; Zhou Q; Deng L
Cell Biochem Funct; 2012 Jun; 30(4):297-302. PubMed ID: 22249904
[TBL] [Abstract][Full Text] [Related]
11. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways.
Calabro P; Samudio I; Willerson JT; Yeh ET
Circulation; 2004 Nov; 110(21):3335-40. PubMed ID: 15545519
[TBL] [Abstract][Full Text] [Related]
12. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway.
Subramaniam S; Shahani N; Strelau J; Laliberté C; Brandt R; Kaplan D; Unsicker K
J Neurosci; 2005 Mar; 25(11):2838-52. PubMed ID: 15772344
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line.
Kodama Y; Baxter RC; Martin JL
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):336-44. PubMed ID: 12204896
[TBL] [Abstract][Full Text] [Related]
17. The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-I-induced c-Jun N-terminal kinase activation.
Lin Y; Yang Q; Wang X; Liu ZG
J Biol Chem; 2006 Aug; 281(33):23525-32. PubMed ID: 16793775
[TBL] [Abstract][Full Text] [Related]
18. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification.
Tintut Y; Parhami F; Boström K; Jackson SM; Demer LL
J Biol Chem; 1998 Mar; 273(13):7547-53. PubMed ID: 9516456
[TBL] [Abstract][Full Text] [Related]
19. IGFs stimulate zebrafish cell proliferation by activating MAP kinase and PI3-kinase-signaling pathways.
Pozios KC; Ding J; Degger B; Upton Z; Duan C
Am J Physiol Regul Integr Comp Physiol; 2001 Apr; 280(4):R1230-9. PubMed ID: 11247849
[TBL] [Abstract][Full Text] [Related]
20. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells.
Grey A; Chen Q; Xu X; Callon K; Cornish J
Endocrinology; 2003 Nov; 144(11):4886-93. PubMed ID: 12960100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
